Status:

COMPLETED

Micardis®. Observational Study in Patients With Essential Hypertension

Lead Sponsor:

Boehringer Ingelheim

Conditions:

Hypertension

Eligibility:

All Genders

18+ years

Brief Summary

This study is designed to supplement, under conditions of usual clinical practice, the data on the efficacy and safety of Micardis® collected during the clinical studies.

Eligibility Criteria

Inclusion

  • Patients of either sex over the age of 18 years suffering from essential hypertension requiring treatment according to the physician

Exclusion

  • Hypersensitivity to the active component or to any of the excipients
  • Pregnancy and lactation
  • Biliary obstructive disorders
  • Severe hepatic impairment
  • Severe renal impairment

Key Trial Info

Start Date :

December 1 1999

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

4532 Patients enrolled

Trial Details

Trial ID

NCT02200094

Start Date

December 1 1999

Last Update

July 25 2014

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.